Vismodegib as Eye-Sparing Neoadjuvant Treatment for Locally Advanced Periocular Basal Cell Carcinoma
INTRODUCTIONLocally-advanced basal cell carcinoma (BCC) often pose considerable therapeutic challenges because of the need to preserve functionality and cosmesis of the affected region.1 In high-risk, aggressive or recurrent tumors of…
Read More





